With estimates to reach USD xx.x billion by 2031, the “United States Raxibacumab Market ” is expected to reach a valuation of USD xx.x billion in 2023, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. United States Raxibacumab Market by Type Segmentation Raxibacumab, a monoclonal antibody, is used primarily… Continue reading United States Raxibacumab Market By Type, Trends And Forecast 2023-2031